Austrian-Nordic is seeking a Director, as well as innovative and experienced scientists to work in the newly established Development Group.
Austrian-Nordic is a biotechnology company based in Vienna, Austria, focusing on the development of novel retroviral vectors and related technologies for the treatment of serious diseases such as cancer.
The Development Group will be instrumental in transferring basic research carried out by Austrian-Nordic and its collaborating academic partners to clinical products. The focus of Austrian-Nordic's current activities lie in the encapsulation of retrovirus producer cells in cellulose sulphate and the optimisation of retroviral vectors.
Austrian-Nordic are seeking scientists with PhD and/or M.D. degrees and academic or industrial experience in the relevant area.
Competitive compensation and benefits are offered commensurate with prior experience. Please send your CV and cover letter indicating the position of interest to: Dr. Brian Salmons, CEO, Austrian-Nordic, Veterinärplatz 1, A-1210 Vienna, Austria.
For more information visit Austrian-Nordic online.